Skip to main content
. 2022 Jul 9;2022:3332421. doi: 10.1155/2022/3332421

Figure 3.

Figure 3

Mean number of injections per period until 48 months (primary outcome). The mean number of intravitreal injections was reduced significantly between 12 and 24 months (P=0.007), between 24 and 36 months (P=0.003), and between 36 and 48 months (P=0.002) compared with the number of injections performed in the first 12 months of follow-up.